Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uri Ben-David

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Molecular and Cellular Therapies|June 10, 2015
Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?Uri Ben-David
Biochimica Et Biophysica Acta|August 19, 2014
Genomic instability, driver genes and cell selection: Projections from cancer to stem cellsUri Ben-David
Stem Cells (Dayton, Ohio)|February 14, 2012
High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cellsUri Ben-David, Nissim Benvenisty
Nature Reviews. Cancer|March 11, 2011
The tumorigenicity of human embryonic and induced pluripotent stem cellsUri Ben-David, Nissim Benvenisty
Nature Reviews. Genetics|September 25, 2019
Context is everything: aneuploidy in cancerUri Ben-David, Angelika Amon
Nature Protocols|March 1, 2014
Chemical ablation of tumor-initiating human pluripotent stem cellsUri Ben-David, Nissim Benvenisty
Molecular & Cellular Oncology|May 24, 2021
Relevance of aneuploidy for cancer therapies targeting the spindle assembly checkpoint and KIF18AYael Cohen-Sharir, Uri Ben-David
Nature Protocols|April 27, 2013
Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profilesUri Ben-David, Yoav Mayshar, Nissim Benvenisty
Cell Stem Cell|August 6, 2011
Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cellsUri Ben-David, Yoav Mayshar, Nissim Benvenisty
Molecular Cell|April 17, 2026
Borne to be wild: ecDNA as a vehicle for oncogenic fusionAdi Tarrab, Lukas Frank, Uri Ben-David
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Therapies|June 10, 2015
Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?Uri Ben-David
Biochimica Et Biophysica Acta|August 19, 2014
Genomic instability, driver genes and cell selection: Projections from cancer to stem cellsUri Ben-David
Stem Cells (Dayton, Ohio)|February 14, 2012
High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cellsUri Ben-David, Nissim Benvenisty
Nature Reviews. Cancer|March 11, 2011
The tumorigenicity of human embryonic and induced pluripotent stem cellsUri Ben-David, Nissim Benvenisty
Nature Reviews. Genetics|September 25, 2019
Context is everything: aneuploidy in cancerUri Ben-David, Angelika Amon
Nature Protocols|March 1, 2014
Chemical ablation of tumor-initiating human pluripotent stem cellsUri Ben-David, Nissim Benvenisty
Molecular & Cellular Oncology|May 24, 2021
Relevance of aneuploidy for cancer therapies targeting the spindle assembly checkpoint and KIF18AYael Cohen-Sharir, Uri Ben-David
Nature Protocols|April 27, 2013
Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profilesUri Ben-David, Yoav Mayshar, Nissim Benvenisty
Cell Stem Cell|August 6, 2011
Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cellsUri Ben-David, Yoav Mayshar, Nissim Benvenisty
Molecular Cell|April 17, 2026
Borne to be wild: ecDNA as a vehicle for oncogenic fusionAdi Tarrab, Lukas Frank, Uri Ben-David
Pageof 8